Some investors might choose to stay out of the famously volatile biotech industry right now, given that equities are already ...
Arrowhead Pharmaceuticals stock could build on its rally in the third quarter, Morgan Stanley says.
Legend Biotech ( LEGN +18.42%) was one of the healthier healthcare stocks on the market as the trading week kicked off on ...
CRISPR Therapeutics (NASDAQ: CRSP), a mid-cap biotech company, achieved a major milestone when it earned approval for the ...
On February 16, Franklin Equity said the biotechnology industry has entered 2026 on a firmer footing following an extended ...
Vir Biotechnology, Inc. (NASDAQ:VIR) is one of the best low priced biotech stocks to invest in. On April 13, Vir ...
Compass Pathways may be the first to benefit from an accelerated approval process.
StockStory.org on MSN
Biotechnology stocks Q3 results: Benchmarking Natera (NASDAQ:NTRA)
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same ...
In 2025, biotechnology stocks had their best year since the COVID-19 pandemic, with the market sector’s two major indexes — the SDPR S&P Biotech ETX (NYSE: XBI) and iShares Biotech ETF (NYSE: IBB) — ...
Vertex Pharmaceuticals (NASDAQ: VRTX) and Mirum Pharmaceuticals (NASDAQ: MIRM) are two biotech stocks that share the same ...
Biotech stocks surged in 2025, driven by FDA approvals, M&A activity, and rising longevity investment. Explore key trends, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results